Simcere Pharmaceutical Group Limited (02096.HK) Stock Price, Chart, News and AI analysis

Q: What is the price performance of SIMCERE PHARMA stock?

The current price of SIMCERE PHARMA is $11.64, it has increased 0.17% in the last trading day.

Q: What are the primary business themes or industries for Simcere Pharmaceutical Group Limited?

Simcere Pharmaceutical Group Limited belongs to Pharmaceuticals industry and the sector is Health Care

Q: What is Simcere Pharmaceutical Group Limited market cap?

Simcere Pharmaceutical Group Limited's current market cap is $30.2B

Home

Stock

02096.HK

SIMCERE PHARMA (02096.HK)

Simcere Pharmaceutical Group Limited

HK$11.64

0.17%

$0.02

CLOSED_MARKET: Jan 16, 16:00:00 HKT

Key Stats

Prev.Close

$11.62

Open

$11.62

Day's Range

$11.44 - $11.78

52 week range

$6.2 - $15.08

Volume

11.0M

Avg.Volume

8.2M

EPS (TTM)

0.40

Dividend yield

Market Cap

$30.2B

What is SIMCERE PHARMA?

Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Trading Mindshare